Top

Published in:

01-01-2010

Stroke in Women: Disparities and Outcomes

Authors: Rebecca W. Persky, Lisa Christine Turtzo, Louise D. McCullough

Published in: Current Cardiology Reports | Issue 1/2010

Abstract

Stroke is the leading cause of disability in the United States and affects 15 million people worldwide. Studies performed in various parts of the world have found differences between sexes in stroke incidence, prevalence, mortality, and outcomes. Although men are at higher risk of stroke for most age groups below age 85 years, after this age the incidence reverses dramatically, with women being much more at risk. Furthermore, recent studies suggest that women have worse recovery than men post-stroke. Many aspects of recovery may influence this outcome, including sex-specific comorbidities, aggressiveness of acute treatment, prevention therapies, and varying degrees of social support and rates of depression. It is important to further define and investigate sex differences in stroke incidence, care, treatment, and outcomes to improve functional recovery in women.

1.•

American Heart Association: Heart Disease and Stroke Statistics—2009 Update. Dallas, TX: American Heart Association; 2009. This is an informative list of recent stroke statistics on incidence, prevalence, and mortality in the United States.

Reeves MJ, Bushnell CD, Howard G, et al.: Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes. Lancet Neurol 2008, 7:915–926.CrossRefPubMed

•• Turtzo LC, McCullough LD: Sex differences in stroke. Cerebrovasc Dis 2008, 26:462–474. This is a comprehensive review on epidemiology, etiology, outcomes, and special circumstances affecting men and women in stroke.CrossRefPubMed

Appelros P, Stegmayr B, Terent A: Sex differences in stroke epidemiology: a systematic review. Stroke 2009, 40:1082–1090.CrossRefPubMed

Towfighi A, Saver JL, Engelhardt R, Ovbiagele B: A midlife stroke surge among women in the United States. Neurology 2007, 69:1898–1904.CrossRefPubMed

Roquer J, Campello AR, Gomis M: Sex differences in first-ever acute stroke. Stroke 2003, 34:1581–1585.CrossRefPubMed

Petrea RE, Beiser AS, Seshadri S, et al.: Gender differences in stroke incidence and post-stroke disability in the Framingham Heart Study. Stroke 2009, 40:1032–1037.CrossRefPubMed

Smith DB, Murphy P, Santos P, et al.: Gender differences in Colorado stroke registry. Stroke 2009, 40:1078–1081.CrossRefPubMed

Lewsey JD, Gillies M, Jhund PS, et al.: Sex differences in incidence, mortality, and survival in individuals with stroke in Scotland, 1986 to 2005. Stroke 2009, 40:1038–1043.CrossRefPubMed

10.

Reeves MJ, Fonarow GC, Zhao X, et al.: Quality of care in women with ischemic stroke in the GWTG program. Stroke 2009, 40:1127–1133.CrossRefPubMed

11.

Lane DA, Lip GYH: Female gender is a risk factor for stroke and thromboembolism in atrial fibrillation patients. Thromb Haemost 2009, 101:802–805.PubMed

12.

Humphries KH, Kerr CR, Connolly SJ, et al.: New-onset atrial fibrillation: sex differences in presentation, treatment and outcome. Circulation 2001, 103:2365–2370.PubMed

13.

Poli D, Antonucci E, Grifoni E, et al.: Gender differences in stroke risk of atrial fibrillation patients on oral anticoagulant treatment. Thromb Haemost 2009, 101:938–942.PubMed

14.

Dearborn JL, McCullough LD: Perception of risk and knowledge of risk factors in women at high risk for stroke. Stroke 2009, 40:1181–1186.CrossRefPubMed

15.

Huxley VH: Sex and the cardiovascular system: the intriguing tale of how women and men regulate cardiovascular function differently. Adv Physiol Educ 2007, 31:17–22.CrossRefPubMed

16.

Lisabeth LD, Brown DL, Hughes R, et al.: Acute stroke symptoms: comparing women and men. Stroke 2009, 40:2031–2036.CrossRefPubMed

17.

Stuart-Shor EM, Wellenius GA, DelloIacono DM, Murray AM: Gender differences in presenting and prodromal stroke symptoms. Stroke 2009, 40:1121–1126.CrossRefPubMed

18.

•• Gargano JW, Wehner S, Reeves MJ: Do presenting symptoms explain sex differences in emergency department delays among patients with acute stroke? Stroke 2009, 40:1114–1120. This is a relevant study on differences in presenting symptoms of stroke and how it affects treatment and quality of care.CrossRefPubMed

19.

Becker JB, Arnold AP, Berkley JD, et al.: Strategies and methods for research on sex difference in brain and behavior. Endocrinology 2005, 146:1650–1673.CrossRefPubMed

20.

Gravholt CH, Juul S, Naeraa RW, Hansen J: Morbidity in Turner syndrome. J Clin Epidemiol 1998, 2:147–158.CrossRef

21.

Carell L, Willard HF: X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature 2005, 434:400–404.CrossRef

22.

McInnes C, McAlpine C, Walters M: Effect of gender on stroke management in Glasgow. Age Ageing 2008, 37:220–222.CrossRefPubMed

23.

National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): Third Report of the National Cholesterol Educational Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002, 106:3143–3421.

24.

LaRosa JC, He J, Vupputuri S: Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials. JAMA 1999, 282:2340–2346.CrossRefPubMed

25.

• McCullough LD, Koerner IP, Hurn PD: Chapter 8 Effects of gender and sex steroids on ischemic injury. Handb Clin Neurol 2008, 92:149–169. This is an informative chapter concerning sex disparities in ischemic injury and the role sex steroids play in sex-specific responses.CrossRefPubMed

26.

Kittner SJ, Stern BJ, Feeser BR, et al.: Stroke in pregnancy. N Engl J Med 1996, 335:768–774.CrossRefPubMed

27.

Tang CH, Wu CS, Lee TH, et al.: Preeclampsia-eclampsia and the risk of stroke among peripartum in Taiwan. Stroke 2009, 40:1162–1168.CrossRefPubMed

28.

Kajantie E, Eriksson JG, Osmond C, et al.: Pre-eclampsia is associated with increased risk of stroke in the adult offspring: the Helinski birth cohort study. Stroke 2009, 40:1176–1180.CrossRefPubMed

29.

Paganini-Hill A: Hormone replacement therapy and stroke: risk, protection, or no effect? Maturitas 2001, 38:243–261.CrossRefPubMed

30.

Wassertheil-Smoller S, Hendrix SL, Limacher M, et al.: Effect of estrogen plus progestin on stroke in postmenopausal women: the women’s health initiative: a randomized trial. JAMA 2003, 289:2673–2684.CrossRefPubMed

31.

Rossouw JE, Anderson GL, Prentice RL, et al.: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from Women’s Health Initiative randomized controlled trial. JAMA 2002, 288:321–333.CrossRefPubMed

32.

Lisabeth LD, Beiser AS, Brown DL, et al.: Age at natural menopause and risk of ischemic stroke: the Framingham Heart Study. Stroke 2009, 40:1044–1049.CrossRefPubMed

33.

Harman SM, Brinton EA, Cedars M, et al.: KEEPS: the Kronos Early Estrogen Prevention Study. Climacteric 2005, 8:3–12.CrossRefPubMed

34.

• Suzuki S, Brown CM, Dela Cruz CD, et al.: Timing of estrogen therapy after ovariectomy dictates the efficacy of its neuroprotective and anti-inflammatory actions. Proc Natl Acad Sci U S A 2007, 104:6013–6018. This is an important study on why timing of hormone replacement therapy is relevant in neuroprotection.CrossRefPubMed

35.

Grodstein F, Manson JE, Colditz GA, et al.: A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med 2000, 133:933–941.PubMed

36.

Prestwood KM, Unson C, Kulldorff M, Cushman M: The effect of different doses of 17beta-estradiol on C-reactive protein, interleukin-6, and lipids in older women. J Gerontol A Biol Sci Med Sci 2004, 59:827–832.PubMed

37.

Mandelzweig L, Goldbourt U, Boyko V, Tanne D: Perceptual, social, and behavioral factors associated with delays in seeking medical care in patients with symptoms of acute stroke. Stroke 2006, 37:1248–1253.CrossRefPubMed

38.

Menon SC, Pandey DK, Morgenstern LB: Critical factors determining access to acute stroke care. Neurology 1998, 51:427–432.PubMed

39.

Gargano JW, Wehner S, Reeves M: Sex differences in acute stroke care in a statewide stroke registry. Stroke 2008, 39:24–29.CrossRefPubMed

40.

Deng YZ, Reeves MJ, Jacobs BS, et al.: IV tissue plasminogen activator use in acute stroke: experience from a statewide registry. Neurology 2006, 66:306–312.CrossRefPubMed

41.

Reeves M, Bhatt A, Jajou P, et al.: Sex differences in the use of intravenous rt-PA thrombolysis treatment for acute ischemic stroke. A meta-analysis. Stroke 2009, 40:1743–1749.CrossRefPubMed

42.

Allen NB, Myers D, Watanabe E, et al.: Utilization of intravenous tissue plasminogen activator for ischemic stroke: are there sex differences? Cerebrovasc Dis 2009, 27:254–258.CrossRefPubMed

43.

Kent DM, Buchan AM, Hill MD: The gender effect in stroke thrombolysis: of CASES, controls, and treatment-effect modification. Neurology 2008, 71:1080–1083.CrossRefPubMed

44.

• Meseguer E, Mazighi M, Labreuche J, et al: Outcomes of intravenous recombinant tissue plasminogen activator therapy according to gender: a clinical registry study and systematic review. Stroke 2009, 40:2104–2110. This is a comprehensive recent review on rt-PA treatment and outcome differences between the sexes.CrossRefPubMed

45.

Howard VJ, Voeks JH, Lutsep HL, et al.: Does sex matter? Thirty-day stroke and death rates after carotid artery stenting in women versus men: results from the carotid revascularization endarterectomy versus stenting trial (CREST) lead-in phase. Stroke 2009, 40:1140–1147.CrossRefPubMed

46.

Turaj W, Slowik A, Wnuk M, Szczudlik A: Gender-related differences in diagnostic evaluation and outcome of ischemic stroke in Poland. Stroke 2009, 40:980–982.CrossRefPubMed

47.

Gray LJ, Sprigg N, Bath PM, et al.: Sex differences in quality of life in stroke survivors: data from the Tinzaparin in Acute Ischaemic Stroke Trial (TAIST). Stroke 2007, 38:2960–2964.CrossRefPubMed

48.

Raju TN, Nelson KB, Ferriero K, Lynch JK: Ischemic perinatal stroke: summary of a workshop sponsored by the National Institute of Child Health and Human Development and the National Institute of Neurological Disorders and Stroke. Pediatrics 2007, 120:609–616.CrossRefPubMed

49.

Bernard TJ, Goldenberg NA: Pediatric arterial ischemic stroke. Pediatr Clin North Am 2008, 55:323–338.CrossRefPubMed

50.

Putalaa J, Metso AJ, Metso TM, et al.: Analysis of 1008 consecutive patients aged 15–49 with first-ever ischemic stroke: the Helsinki young stroke registry. Stroke 2009, 40:1195–1203.CrossRef

Title: Stroke in Women: Disparities and Outcomes
Authors: Rebecca W. Persky
Lisa Christine Turtzo
Louise D. McCullough
Publication date: 01-01-2010
Publisher: Current Science Inc.
Published in: Current Cardiology Reports / Issue 1/2010
Print ISSN: 1523-3782
Electronic ISSN: 1534-3170
DOI: https://doi.org/10.1007/s11886-009-0080-2

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Stroke in Women: Disparities and Outcomes

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2010

The Evolution of Transcranial Laser Therapy for Acute Ischemic Stroke, Including a Pooled Analysis of NEST-1 and NEST-2

Radiation Dose Reduction in CT Coronary Angiography

Combined Anatomic and Perfusion Imaging of the Heart

Primary Intracranial Stenting in Acute Ischemic Stroke

The Combination of Clopidogrel Plus Aspirin to Treat Atrial Fibrillation

Ultrasound- and Microspheres-Enhanced Thrombolysis for Stroke Treatment: State of the Art

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page